{"DataElement":{"publicId":"6564105","version":"1.1","preferredName":"Treatment Cohort Study 10204 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10204 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10204_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6564076","version":"1.1","preferredName":"10204 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6564076v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SSc1","valueDescription":"SSc1: Mild (MRSS < 15 and stable without DMARDs AND no cardiopulmonary, renal, or active musculoskeletal [arthritis/myositis] involvement)","ValueMeaning":{"publicId":"6564095","version":"1","preferredName":"SSc1: Mild (MRSS < 15 and stable without DMARDs AND no cardiopulmonary, renal, or active musculoskeletal [arthritis/myositis] involvement)","longName":"6564095","preferredDefinition":"SSc1: Mild (MRSS < 15 and stable without DMARDs AND no cardiopulmonary, renal, or active musculoskeletal [arthritis/myositis] involvement)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FEED-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3175-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"CD3","valueDescription":"CD3: Severe (remission or mild disease, biologic immune suppression)","ValueMeaning":{"publicId":"6564096","version":"1","preferredName":"CD3: Severe (remission or mild disease, biologic immune suppression)","longName":"6564096","preferredDefinition":"CD3: Severe (remission or mild disease, biologic immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C712-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-317F-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"CD2","valueDescription":"CD2: Moderate (remission, non-biologic immune suppression)","ValueMeaning":{"publicId":"6564097","version":"1","preferredName":"CD2: Moderate (remission, non-biologic immune suppression)","longName":"6564097","preferredDefinition":"CD2: Moderate (remission, non-biologic immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C735-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3189-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"CD1","valueDescription":"CD1: Mild (remission, no immune suppression)","ValueMeaning":{"publicId":"6564098","version":"1","preferredName":"CD1: Mild (remission, no immune suppression)","longName":"6564098","preferredDefinition":"CD1: Mild (remission, no immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C758-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3193-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"UC3","valueDescription":"UC3: Severe (remission or mild disease, biologic immune suppression)","ValueMeaning":{"publicId":"6564099","version":"1","preferredName":"UC3: Severe (remission or mild disease, biologic immune suppression)","longName":"6564099","preferredDefinition":"UC3: Severe (remission or mild disease, biologic immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C77B-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-319D-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"UC2","valueDescription":"UC2: Moderate (remission, non-biologic immune suppression)","ValueMeaning":{"publicId":"6564100","version":"1","preferredName":"UC2: Moderate (remission, non-biologic immune suppression)","longName":"6564100","preferredDefinition":"UC2: Moderate (remission, non-biologic immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C79E-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31A7-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"UC1","valueDescription":"UC1: Mild (remission, no immune suppression)","ValueMeaning":{"publicId":"6564101","version":"1","preferredName":"UC1: Mild (remission, no immune suppression)","longName":"6564101","preferredDefinition":"UC1: Mild (remission, no immune suppression)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C7C1-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31B1-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"MS2","valueDescription":"MS2: Active MS or on natalizumab, fingolimod, or ocrelizumab","ValueMeaning":{"publicId":"6564102","version":"1","preferredName":"MS2: Active MS or on natalizumab, fingolimod, or ocrelizumab","longName":"6564102","preferredDefinition":"MS2: Active MS or on natalizumab, fingolimod, or ocrelizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E5A47-C7E4-02F9-E053-F662850A4E01","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31BB-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"NS2","valueDescription":"NS2: History of vital organ involvement or severe autoimmune diseases, although the condition should be under control for enrollment on this trial. Low dose steroid is allowed.","ValueMeaning":{"publicId":"6564079","version":"1","preferredName":"NS2: History of vital organ involvement or severe autoimmune diseases, although the condition should be under control for enrollment on this trial. Low dose steroid is allowed.","longName":"6564079","preferredDefinition":"NS2: History of vital organ involvement or severe autoimmune diseases, although the condition should be under control for enrollment on this trial. Low dose steroid is allowed.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FCBD-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31D9-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"NS1B","valueDescription":"NS1B: Patients without active autoimmune disease and require low dose steroid up to 10 mg of prednisone. No history of vital organ involvement or severe autoimmune diseases.","ValueMeaning":{"publicId":"6564080","version":"1","preferredName":"NS1B: Patients without active autoimmune disease and require low dose steroid up to 10 mg of prednisone. No history of vital organ involvement or severe autoimmune diseases.","longName":"6564080","preferredDefinition":"NS1B: Patients without active autoimmune disease and require low dose steroid up to 10 mg of prednisone. No history of vital organ involvement or severe autoimmune diseases.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FCE0-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31E3-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"NS1A","valueDescription":"NS1A: No active autoimmune disease and NOT on steroids. No history of vital organ involvement.","ValueMeaning":{"publicId":"6564081","version":"1","preferredName":"NS1A: No active autoimmune disease and NOT on steroids. No history of vital organ involvement.","longName":"6564081","preferredDefinition":"NS1A: No active autoimmune disease and NOT on steroids. No history of vital organ involvement.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FD03-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-31ED-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SLE3","valueDescription":"SLE3: Severe","ValueMeaning":{"publicId":"6564085","version":"1","preferredName":"SLE3: Severe","longName":"6564085","preferredDefinition":"SLE3: Severe","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FD8F-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3215-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SLE2","valueDescription":"SLE2: Moderate","ValueMeaning":{"publicId":"6564086","version":"1","preferredName":"SLE2: Moderate","longName":"6564086","preferredDefinition":"SLE2: Moderate","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FDB2-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-321F-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SLE1","valueDescription":"SLE1: Mild","ValueMeaning":{"publicId":"6564087","version":"1","preferredName":"SLE1: Mild","longName":"6564087","preferredDefinition":"SLE1: Mild","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FDD5-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3229-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"RA2","valueDescription":"RA2: Moderate or severe disease activity by the CLDAI > 10","ValueMeaning":{"publicId":"6564088","version":"1","preferredName":"RA2: Moderate or severe disease activity by the CLDAI > 10","longName":"6564088","preferredDefinition":"RA2: Moderate or severe disease activity by the CLDAI > 10","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FDF8-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3233-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"RA1","valueDescription":"RA1: Low disease activity or remission Clinical Disease Activity Index ([CLDAI] </= 10)","ValueMeaning":{"publicId":"6564089","version":"1","preferredName":"RA1: Low disease activity or remission Clinical Disease Activity Index ([CLDAI] </= 10)","longName":"6564089","preferredDefinition":"RA1: Low disease activity or remission Clinical Disease Activity Index ([CLDAI] </= 10)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FE1B-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-323D-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"DEM3","valueDescription":"DEM3: Severe (active but stable lung disease or otherwise requiring biologic/cyclophosphamide/FK506)","ValueMeaning":{"publicId":"6564090","version":"1","preferredName":"DEM3: Severe (active but stable lung disease or otherwise requiring biologic/cyclophosphamide/FK506)","longName":"6564090","preferredDefinition":"DEM3: Severe (active but stable lung disease or otherwise requiring biologic/cyclophosphamide/FK506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FE3E-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3247-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"DEM2","valueDescription":"DEM2: Moderate (CDASI-a >/= 15 or requiring nonbiologic immunosuppression; can have active myositis but mild and stable; no current active lung disease)","ValueMeaning":{"publicId":"6564091","version":"1","preferredName":"DEM2: Moderate (CDASI-a >/= 15 or requiring nonbiologic immunosuppression; can have active myositis but mild and stable; no current active lung disease)","longName":"6564091","preferredDefinition":"DEM2: Moderate (CDASI-a >/= 15 or requiring nonbiologic immunosuppression; can have active myositis but mild and stable; no current active lung disease)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FE61-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3251-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"DEM1","valueDescription":"DEM1: Mild (CDASI-a < 15 and no immunosuppression other than antimalarial and no history of lung disease; no clinically active myositis)","ValueMeaning":{"publicId":"6564092","version":"1","preferredName":"DEM1: Mild (CDASI-a < 15 and no immunosuppression other than antimalarial and no history of lung disease; no clinically active myositis)","longName":"6564092","preferredDefinition":"DEM1: Mild (CDASI-a < 15 and no immunosuppression other than antimalarial and no history of lung disease; no clinically active myositis)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FE84-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-325B-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SSc3","valueDescription":"SSc3: Severe (MRSS > 35 OR requiring biologics or cyclophosphamide for active skin, lung, or musculoskeletal involvement)","ValueMeaning":{"publicId":"6564093","version":"1","preferredName":"SSc3: Severe (MRSS > 35 OR requiring biologics or cyclophosphamide for active skin, lung, or musculoskeletal involvement)","longName":"6564093","preferredDefinition":"SSc3: Severe (MRSS > 35 OR requiring biologics or cyclophosphamide for active skin, lung, or musculoskeletal involvement)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FEA7-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-3265-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SSc2","valueDescription":"SSc2: Moderate (MRSS 15-34 OR stable or non-biologic DMARDs for skin, lung, or musculoskeletal involvement)","ValueMeaning":{"publicId":"6564094","version":"1","preferredName":"SSc2: Moderate (MRSS 15-34 OR stable or non-biologic DMARDs for skin, lung, or musculoskeletal involvement)","longName":"6564094","preferredDefinition":"SSc2: Moderate (MRSS 15-34 OR stable or non-biologic DMARDs for skin, lung, or musculoskeletal involvement)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E4905-FECA-5E1B-E053-F662850AAE91","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-326F-6696-E053-F662850A8E03","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"MS1B","valueDescription":"MS1B: Stable MS (>= 1 year)","ValueMeaning":{"publicId":"6689487","version":"1","preferredName":"MS1B: Stable MS (>= 1 year)","longName":"6689487","preferredDefinition":"MS1B: Stable MS (>= 1 year)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86308066-3296-6696-E053-F662850A8E03","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-32AF-6696-E053-F662850A8E03","beginDate":"2019-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"MS1A","valueDescription":"MS1A: Stable MS (>= 5 years)","ValueMeaning":{"publicId":"6689488","version":"1","preferredName":"MS1A: Stable MS (>= 5 years)","longName":"6689488","preferredDefinition":"MS1A: Stable MS (>= 5 years)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86308066-32B9-6696-E053-F662850A8E03","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86308066-32D2-6696-E053-F662850A8E03","beginDate":"2019-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"SJS1","valueDescription":null,"ValueMeaning":{"publicId":"11060760","version":"1","preferredName":"EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) (Seror, et al., 2010)","longName":"11060760v1.00","preferredDefinition":"EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) (Seror, et al., 2010)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E96892-69C9-348A-E053-731AD00AA16A","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5E96892-69CA-348A-E053-731AD00AA16A","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","deletedIndicator":"No"},{"value":"PSOPSA","valueDescription":null,"ValueMeaning":{"publicId":"11060761","version":"1","preferredName":"PsO as diagnosed by a dermatologist or PsA as diagnosed by a rheumatologist and/or by CASPAR criteria according to Tillett W, et al.","longName":"11060761v1.00","preferredDefinition":"PsO as diagnosed by a dermatologist or PsA as diagnosed by a rheumatologist and/or by CASPAR criteria according to Tillett W, et al.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E96F3B-06B2-355D-E053-731AD00AC4C5","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5E96F3B-06B3-355D-E053-731AD00AC4C5","beginDate":"2022-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-10","modifiedBy":"KUMMEROA","dateModified":"2022-08-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86308066-315F-6696-E053-F662850A8E03","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"SOKKERL","dateModified":"2022-08-22","changeDescription":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED and added End Date in preparation of OneData.; LS curated /10204. version 1.1 updated PVs. ls 4/10/19","administrativeNotes":"2022.8.10 Needed to version so took this one back out of retirement. This VD not used on any form. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Subgroup","type":"Preferred Question Text","description":"Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"862D5668-F331-707A-E053-F662850A2FFA","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-10","modifiedBy":"SOKKERL","dateModified":"2022-08-22","changeDescription":"10.16.20 TL changed WFS from RETIRED DELETED to RETIRED ARCHIVED in preparation of OneData.; LS Curated for 10204","administrativeNotes":"2022.8.10 Took out of retirement due to reusing VD 1.1 for Ticket Request CADSR0001350. ak","unresolvedIssues":null,"deletedIndicator":"No"}}